BIOVEST INTERNATIONAL INC (BVTI.OB) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 51 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jul 9, 2013 involved a transaction of 55,800 shares valued at $0.
No significant insider buying has been recorded for BVTI.OB in the recent period.
No significant insider selling has been recorded for BVTI.OB in the recent period.
Based on recent SEC filings, insider sentiment for BVTI.OB is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at BIOVEST INTERNATIONAL INC (BVTI.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading BVTI.OB stock, having executed 51 transactions in the past 90 days. The most active insider is Biopharmaceuticals Inc Accentia (Executive), who has made 17 transactions totaling $3.2M.
Get notified when executives and directors at BVTI.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 9, 2013 | D. Hirschel Mark | Executive | Other | 55,800 | $N/A | $0 | |
| Jul 9, 2013 | E. Odonnell Francis Jr | Executive | Other | 18,306 | $N/A | $0 | |
| Jul 9, 2013 | E. Odonnell Francis Jr | Executive | Other | 84,951 | $N/A | $0 | |
| Jul 9, 2013 | E. Odonnell Francis Jr | Executive | Other | 111,610 | $N/A | $0 | |
| Jul 9, 2013 | E. Odonnell Francis Jr | Executive | Other | 2,991 | $N/A | $0 | |
| Jul 9, 2013 | E. Osman Ronald | Executive | Other | 8,680,000 | $N/A | $0 | |
| Jul 9, 2013 | E. Osman Ronald | Executive | Other | 18,428 | $N/A | $0 | |
| Jul 9, 2013 | E. Osman Ronald | Executive | Other | 17,360,000 | $N/A | $0 | |
| Jul 9, 2013 | J. Pappas Peter | Executive | Other | 524,545 | $N/A | $0 | |
| Jul 9, 2013 | J. Pappas Peter | Executive | Other | 968,000 | $N/A | $0 | |
| Jul 9, 2013 | Sitilides John | Executive | Other | 27,927 | $N/A | $0 | |
| Feb 22, 2013 | Inc Accentia Biopharmaceuticals | Executive | Other | 4,794,373 | $0.12 | $575.3K | Large |
| Aug 7, 2012 | Inc Accentia Biopharmaceuticals | Executive | Other | 400,000 | $0.75 | $300.0K | |
| Aug 7, 2012 | Inc Accentia Biopharmaceuticals | Executive | Other | 124,494 | $0.39 | $48.6K | |
| May 31, 2012 | Inc Accentia Biopharmaceuticals | Executive | Other | 400,000 | $0.75 | $300.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 39 | $3.2M | 84.4% |
Exercise(M) | 6 | $350.3K | 9.2% |
Payment(F) | 3 | $230.8K | 6.0% |
Conversion(C) | 1 | $15.2K | 0.4% |
Gift(G) | 1 | $0 | 0.0% |
Award(A) | 1 | $0 | 0.0% |
Insider activity at BIOVEST INTERNATIONAL INC shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.7 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Biopharmaceuticals Inc Accentia, has transacted $3.2M during this period.